Published in Medical Devices and Surgical Technology Week, August 1st, 2004
The donation is part of Bayer BP's continuing commitment to improve the state of care for people living with hemophilia around the world.
The donated Kogenate FS has an approximate market value of $9.3 million dollars and will be used to assist the WFH with hemophilia care in 27 countries around the world. The product will be used for emergency lifesaving situations or for patients who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.